Stock AnalizIdex Corp. IEX
Fluid Controls · IPO 1989 · data as of November 13, 2026
Idex Corp. (IEX) is a industrial company listed in the US with a market value of about $17.5B. In the twelve months to September 30, 2026 it had revenue of $3.7B and net income of $536M, a net margin of 14.6%.
Its overall Stock Analiz score is 2.2 out of 5 (weak). The strongest part is financial health (5/5); the weakest is value (0/5).
Key numbers: a P/E of 33.0, a price to free cash flow of 26.2, 5-year revenue growth of 8% a year, a 5-year average ROIC of 11%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 36% below the current price.
Score: 2.2 / 5
Checks passed
- 5-year revenue growth above 8% a year
- Profitable 5 years in a row
- More cash than debt, or low debt to equity
- Positive free cash flow
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
- Liabilities below 60% of assets
- Pays a dividend
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7B | $3.5B | $3.3B | $3.3B | $3.2B | $2.8B | $2.4B | $2.5B | $2.5B | $2.3B | $2.1B |
| Net income | $536M | $483M | $505M | $596M | $587M | $449M | $378M | $426M | $411M | $337M | $271M |
| Free cash flow | $667M | $617M | $603M | $627M | $489M | $493M | $518M | $477M | $423M | $389M | $362M |
| EPS (diluted) | $7.20 | $6.41 | $6.64 | $7.85 | $7.71 | $5.88 | $4.94 | $5.56 | $5.29 | $4.36 | $3.53 |
| Net margin | 14.6% | 14.0% | 15.4% | 18.2% | 18.4% | 16.2% | 16.1% | 17.1% | 16.5% | 14.7% | 12.8% |
| ROIC | — | 8.9% | 9.1% | 11.5% | 12.7% | 12.0% | 11.3% | 14.4% | 15.5% | 13.5% | 11.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 14 analysts is $262.93, 11% above the current price; targets range from $228.00 to $283.00; the consensus rating is “Buy”; expected EPS is $8.95 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Idex’s P/E ratio?
About 33.0, based on the last twelve months of diluted earnings per share (forward P/E about 25.1).
Is Idex stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 36% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Idex pay a dividend?
Yes. The dividend yield is about 1.22%, and it has paid dividends for 10 years in our data.
Is Idex a good stock to buy?
We do not give buy or sell advice. Idex scores 2.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.